Jump to main content
Jump to site search


Hypoxia-augmented and photothermally-enhanced ferroptotic therapy with high specificity and efficiency

Author affiliations

Abstract

The rigorous reaction conditions (sufficient H2O2 and a low pH value) of an efficient Fenton reaction limit its further biomedical translation. Therefore, it is urgent to improve the efficacy of the Fenton reaction at the tumor site for efficient ferroptotic therapy. Herein, a hypoxia-responsive-Azo–BSA functionalized biomimetic nanoreactor (Fe(III)-GA/GOx@ZIF-Azo), encapsulating ultrasmall ferric-gallic acid coordination polymer nanoparticles (Fe(III)-GA) and glucose oxidase (GOx) into a zeolitic imidazolate framework (ZIF), was constructed for tumor ablation through an intensive Fenton reaction accelerated by not only sustained Fe2+ and H2O2 supply but also low pH and photothermal stimulation. Moreover, Azo achieved charge reversal in a hypoxia microenvironment caused by the sustained oxygen consumption by GOx, which resulted in selective and enhanced tumor accumulation based on the hypoxia-activated positive feedback cellular uptake. This rationally designed biomimetic nanoreactor might lay a foundation for the clinical translation of ferroptotic therapy.

Graphical abstract: Hypoxia-augmented and photothermally-enhanced ferroptotic therapy with high specificity and efficiency

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Oct 2019, accepted on 12 Nov 2019 and first published on 13 Nov 2019


Article type: Paper
DOI: 10.1039/C9TB02268F
J. Mater. Chem. B, 2020, Advance Article

  •   Request permissions

    Hypoxia-augmented and photothermally-enhanced ferroptotic therapy with high specificity and efficiency

    P. An, D. Gu, Z. Gao, F. Fan, Y. Jiang and B. Sun, J. Mater. Chem. B, 2020, Advance Article , DOI: 10.1039/C9TB02268F

Search articles by author

Spotlight

Advertisements